Hedge funds collectively reduced their aggregate holdings in Eli Lilly (LLY) by 42,110 shares, a 5.66% decline to 701,839 shares, between the first and second quarters of 2025, according to analysis of recent 13F filings for the 06/30/2025 reporting period. This significant aggregate reduction across a broad sample of institutional investors, despite the inherent limitations of 13F data to only long positions, suggests a notable shift in institutional sentiment and positioning towards LLY.
Institutional sentiment towards Eli Lilly (LLY) appears to have cooled during the second quarter of 2025, as evidenced by a net reduction in holdings across a wide sample of 13F filers. The most telling metric is the aggregate decrease of 42,110 shares held by funds between March 31 and June 30, 2025, representing a significant 5.66% decline in institutional ownership from 743,949 to 701,839 shares. While a smaller, more recent sample of 28 filers showed a net increase in share count, this was driven by large purchases from just two funds and contradicted by 10 funds reducing their positions. Furthermore, the market value of holdings in this smaller sample paradoxically fell by over $35 million, suggesting these transactions may have occurred at different price points or that investors trimmed positions as the stock price changed during the quarter. The broader, aggregate data indicating a net institutional exit is the more salient signal, pointing towards widespread profit-taking or a strategic reduction in exposure to LLY among a notable portion of the smart money.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly negative
Sentiment Score
-0.25
Ticker Sentiment
